← Leaderboards
Ana Aparicio
University Of Southern California
$635,245
Attributed
$1,887,181
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $636.6K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,887,181 · 2
By mechanism
R01$1,877,904 · 1
M01$9,277 · 1
Top collaborators
- Daniel Edward Frigo3 shared
- Padmanee Sharma3 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Myron Fredric Goodman$33,678,481
- Heinz Josef Lenz$20,123,312
- Stephen I Shibata$1,279,059
- Kai Wang$10,901,792
- Bo Han$926,777
Others in their field
Top investigators on “Evaluation”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- David Heimbrook · Leidos Biomedical Research, Inc.$564,050,020
- Lawrence Corey · Fred Hutchinson Cancer Center$559,122,174
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,869,793
- Jeffrey P Krischer · University Of South Florida$466,087,841
- Judith S. Currier · University Of California Los Angeles$403,175,569
Research focus
EvaluationPeripheral BloodClinical ResearchDoseCellsAntitumor ResponseAndrogensCombined Modality TherapyBiological MarkersArgininosuccinate SynthaseBiomarker IdentificationBiopsyCancer BiologyCarboplatinAdvanced Prostate CancerCell PhysiologyArginine DeiminaseCell ModelChemotherapyCitrullineClinical DataCd8-Positive T-LymphocytesClinical TrialsArginine
Grant awards (4)
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)$636,578
R01 · FY2025 · CA · contact PI
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)$604,748
R01 · FY2024 · CA · contact PI
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)$636,578
R01 · FY2023 · CA · contact PI
A PHASE I TRIAL OF DAILY 5- AZA 2'DEOXYCYTIDINE (DAC) AND SODIUM PHENYLBUTYRA$9,277
M01 · FY2009 · RR · contact PI